The feasibility study of non-invasive fetal trisomy 18 and 21 detection with semiconductor sequencing platform
- PMID: 25329639
- PMCID: PMC4203771
- DOI: 10.1371/journal.pone.0110240
The feasibility study of non-invasive fetal trisomy 18 and 21 detection with semiconductor sequencing platform
Abstract
Objective: Recent non-invasive prenatal testing (NIPT) technologies are based on next-generation sequencing (NGS). NGS allows rapid and effective clinical diagnoses to be determined with two common sequencing systems: Illumina and Ion Torrent platforms. The majority of NIPT technology is associated with Illumina platform. We investigated whether fetal trisomy 18 and 21 were sensitively and specifically detectable by semiconductor sequencer: Ion Proton.
Methods: From March 2012 to October 2013, we enrolled 155 pregnant women with fetuses who were diagnosed as high risk of fetal defects at Xiamen Maternal & Child Health Care Hospital (Xiamen, Fujian, China). Adapter-ligated DNA libraries were analyzed by the Ion Proton™ System (Life Technologies, Grand Island, NY, USA) with an average 0.3× sequencing coverage per nucleotide. Average total raw reads per sample was 6.5 million and mean rate of uniquely mapped reads was 59.0%. The results of this study were derived from BWA mapping. Z-score was used for fetal trisomy 18 and 21 detection.
Results: Interactive dot diagrams showed the minimal z-score values to discriminate negative versus positive cases of fetal trisomy 18 and 21. For fetal trisomy 18, the minimal z-score value of 2.459 showed 100% positive predictive and negative predictive values. The minimal z-score of 2.566 was used to classify negative versus positive cases of fetal trisomy 21.
Conclusion: These results provide the evidence that fetal trisomy 18 and 21 detection can be performed with semiconductor sequencer. Our data also suggest that a prospective study should be performed with a larger cohort of clinically diverse obstetrics patients.
Conflict of interest statement
Figures
Similar articles
-
Comparison of two high-throughput semiconductor chip sequencing platforms in noninvasive prenatal testing for Down syndrome in early pregnancy.BMC Med Genomics. 2016 Apr 30;9(1):22. doi: 10.1186/s12920-016-0182-9. BMC Med Genomics. 2016. PMID: 27129388 Free PMC article.
-
Open source non-invasive prenatal testing platform and its performance in a public health laboratory.Prenat Diagn. 2016 Jun;36(6):530-6. doi: 10.1002/pd.4819. Epub 2016 Apr 24. Prenat Diagn. 2016. PMID: 27027563
-
Feasibility study of semiconductor sequencing for noninvasive prenatal detection of fetal aneuploidy.Clin Chem. 2013 May;59(5):846-9. doi: 10.1373/clinchem.2012.196725. Epub 2013 Jan 30. Clin Chem. 2013. PMID: 23364181
-
Non-invasive prenatal testing for fetal chromosomal abnormalities by low-coverage whole-genome sequencing of maternal plasma DNA: review of 1982 consecutive cases in a single center.Ultrasound Obstet Gynecol. 2014 Mar;43(3):254-64. doi: 10.1002/uog.13277. Epub 2014 Feb 10. Ultrasound Obstet Gynecol. 2014. PMID: 24339153 Review.
-
[Combined first trimester screening and cell-free fetal DNA - “next generation screening”].Ultraschall Med. 2014 Jun;35(3):229-36. doi: 10.1055/s-0034-1366353. Epub 2014 Apr 24. Ultraschall Med. 2014. PMID: 24764214 Review. German.
Cited by
-
Feasibility of mNGS in joint replacement patients exhibiting elevated ESR and CRP levels without an underlying diagnosis.Eur J Med Res. 2024 Oct 26;29(1):515. doi: 10.1186/s40001-024-02118-6. Eur J Med Res. 2024. PMID: 39456072 Free PMC article.
-
Identification of prosthetic joint infection by Candida using metagenomic shotgun sequencing.Access Microbiol. 2023 Oct 26;5(10):000425. doi: 10.1099/acmi.0.000425. eCollection 2023. Access Microbiol. 2023. PMID: 37970089 Free PMC article.
-
The Clinical Impact of Metagenomic Next-Generation Sequencing (mNGS) Test in Hospitalized Patients with Suspected Sepsis: A Multicenter Prospective Study.Diagnostics (Basel). 2023 Jan 16;13(2):323. doi: 10.3390/diagnostics13020323. Diagnostics (Basel). 2023. PMID: 36673134 Free PMC article.
-
Characteristics of the pulmonary microbiota in patients with mild and severe pulmonary infection.Front Cell Infect Microbiol. 2023 Oct 12;13:1227581. doi: 10.3389/fcimb.2023.1227581. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37900322 Free PMC article.
-
Metagenomic Next-Generation Sequencing for Pathogens in Bronchoalveolar Lavage Fluid Improves the Survival of Patients with Pulmonary Complications After Allogeneic Hematopoietic Stem Cell Transplantation.Infect Dis Ther. 2023 Aug;12(8):2103-2115. doi: 10.1007/s40121-023-00850-w. Epub 2023 Aug 4. Infect Dis Ther. 2023. PMID: 37541984 Free PMC article.
References
-
- Morgan S, Delbarre A, Ward P (2013) Impact of introducing a national policy for prenatal Down syndrome screening on the diagnostic invasive procedure rate in England. Ultrasound Obstet Gynecol 41: 526–529. - PubMed
-
- ACOG Committee on Practice Bulletins (2007) ACOG Practice Bulletin No. 77: screening for fetal chromosomal abnormalities. Obstet Gynecol 109: 217–227. - PubMed
-
- Nicolaides KH (2011) Screening for fetal aneuploidies at 11 to 13 weeks. Prenat Diagn 31: 7–15. - PubMed
-
- Fortuny A, Borrell A, Soler A, Casals E, Costa D, et al. (1995) Chorionic villus sampling by biopsy forceps. Results of 1580 procedures from a single centre. Prenat Diagn 15: 541–550. - PubMed
-
- Crandall BF, Kulch P, Tabsh K (1994) Risk assessment of amniocentesis between 11 and 15 weeks: comparison to later amniocentesis controls. Prenat Diagn 14: 913–919. - PubMed
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical